The Prototype You Built in the Lab Is Not a Product and Never Will Be

You built something that works. Reproducibly, in your lab, under controlled conditions, with you or your postdoc running it. Investors have seen the demo. Your thesis committee was impressed. A couple of potential customers nodded along during the pitch.

Photo by Jakub Zerdzicki on Pexels.

None of that means you have a product.

This distinction quietly kills more deep tech startups than bad science or bad fundraising. Founders confuse proof-of-concept with product-readiness, and the gap between the two is where runway goes to die.

What a Lab Prototype Actually Proves

Your prototype proves that the underlying phenomenon is real and controllable under the conditions you set up. That's genuinely valuable. Getting the science right is hard, and plenty of ventures fail before they even reach your stage.

But notice what that sentence says: conditions you set up. You controlled the temperature, the substrate quality, the humidity, the purity of reagents, the calibration of instruments, the expertise of the operator. A customer's facility controls none of those things the way you do.

When a manufacturing partner or early customer runs your process, they will discover failure modes you have never seen. Not because they're incompetent. Because variability is the default state of the world outside your lab, and your prototype was never stress-tested against it.

The Translation Stack Nobody Warns You About

Moving from prototype to product requires solving four distinct problems, roughly in this order:

graph TD
    A[Lab Prototype] --> B(Reproducibility Under Variable Conditions)
    B --> C(Manufacturability at Target Cost)
    C --> D{Regulatory or Certification Requirements}
    D --> E[Deployable Product]

Most technical founders have a solid handle on the first node. They have almost no intuition about the others.

Reproducibility under variable conditions means your process works when someone who is not you runs it, with reagents from a different supplier lot, in a facility that runs slightly warmer than yours. This requires design-of-experiments work that most academic labs never bother with because publications don't reward it.

Manufacturability at target cost means the unit economics of your process have to fit inside a price point a customer will actually pay. If your prototype uses $400 worth of consumables per run and the market rate for your output is $15, the science being real doesn't save you. This is where a lot of biosensor and specialty materials startups quietly fold.

Regulatory or certification requirements depend on your sector, but they almost always demand documentation your lab never generated. Design history files, material safety data, process validation records. Your notebook entries are not enough.

The Mistake That Compounds Everything

Here's where founders make the problem worse: they raise a seed round based on the prototype, hire a couple of engineers, and tell them to "scale it up." The engineers, trying to do their jobs, start optimizing the process for manufacturability. Within six months, the thing they're building looks different enough from the prototype that you have to re-validate the core science claims.

You're not behind schedule. You've restarted.

The fix is boring and unsexy: treat prototype-to-product as its own project with its own scope, budget, and timeline before you go raise money on the premise that scaling is easy. Talk to a contract manufacturer early, not when you need them. Find out where your process breaks under their constraints before you've promised a customer delivery in Q3.

What Customers Are Actually Buying

Sophisticated buyers in industrial, medical, and defense markets have been burned by prototype demos before. What they're evaluating when they agree to a pilot isn't whether your science is interesting. They're asking whether your team understands the difference between a prototype and a product, and whether you have a credible plan to close that gap.

If your pitch deck shows the prototype performing beautifully and then jumps straight to market size, you've already lost that room. They know something you haven't acknowledged.

Say it out loud before they do: "Here is where we are, here is the translation work still ahead of us, here is why we understand each of those steps, and here is what we need to get through them." That honesty doesn't weaken your position. It's the only thing that makes your demo credible instead of suspicious.

The science got you this far. Getting to a product requires a different discipline, and the sooner you treat it as such, the less runway you'll burn discovering that the hard way.